Korro Bio Statistics
NASDAQ: KRROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.18-0.01 (-0.08%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Korro Bio by the numbers
Korro Bio has a market capitalization of $167.2 million based on 13.73M shares outstanding. With trailing EPS of $-8.89, Korro Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.4% above its 50-day average and 0.1% above its 200-day average.
Average daily trading volume is 186.03K shares, or about $2.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KRRO valuation vs. peer median
| Metric | KRRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $167.18M | $171.38M | -2% |
| Avg. volume | 186.03K | 287.27K | -35% |
Peer median across 8 companies: ABEO, TRDA, EMIS, SIGA, VOGX, NATR, ORMP, ADCT.
Valuation
- Market cap
- $167.18M
- Price / sales (latest FY)
- 26.15
- EPS (TTM)
- $-8.89
- Shares outstanding
- 13.73M
Price and trading
- Previous close
- 12.19
- Open
- 12.03
- Day range
- 12.01 – 12.95
- 52-week range
- 5.20 – 17.35
- 52-week change
- +93.95%
- Beta
- —
- Volume
- 123.52K
- Average volume
- 186.03K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 167.18M
- Forward Pe
- -2.85
- Eps
- -8.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.35
- Week52 Low
- 5.20
- Avg Volume
- 186.03K
- Shares Outstanding
- 13.73M
- Ma50
- 11.78
- Ma200
- 12.16
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -29.81%
- Pct From52w Low
- 134.05%